 |
PDBsum entry 6k1q
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
6k1q
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Human endothelin receptor type-b in complex with inverse agonist irl2500
|
|
Structure:
|
 |
Endothelin b receptor,endolysin,endothelin b receptor. Chain: a. Synonym: et-br,endothelin receptor non-selective type,lysis protein, lysozyme,muramidase,et-br,endothelin receptor non-selective type. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens, enterobacteria phage t4. Human. Organism_taxid: 9606, 10665. Gene: ednrb, etrb. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.224
|
R-free:
|
0.265
|
|
|
Authors:
|
 |
C.Nagiri,W.Shihoya,O.Nureki
|
|
Key ref:
|
 |
C.Nagiri
et al.
(2019).
Crystal structure of human endothelin ETB receptor in complex with peptide inverse agonist IRL2500.
Commun Biol,
2,
236.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-May-19
|
Release date:
|
17-Jul-19
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.2.1.17
- lysozyme.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of the 1,4-beta-linkages between N-acetyl-D-glucosamine and N-acetylmuramic acid in peptidoglycan heteropolymers of the prokaryotes cell walls.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Commun Biol
2:236
(2019)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human endothelin ETB receptor in complex with peptide inverse agonist IRL2500.
|
|
C.Nagiri,
W.Shihoya,
A.Inoue,
F.M.N.Kadji,
J.Aoki,
O.Nureki.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Endothelin receptors (ETA and ETB) are G-protein-coupled
receptors activated by endothelin-1 and are involved in blood pressure
regulation. IRL2500 is a peptide-mimetic of the C-terminal tripeptide of
endothelin-1, and has been characterized as a potent ETB-selective
antagonist, which has preventive effects against brain edema. Here, we report
the crystal structure of the human ETB receptor in complex with
IRL2500 at 2.7 Å-resolution. The structure revealed the different binding
modes between IRL2500 and endothelin-1, and provides structural insights into
its ETB-selectivity. Notably, the biphenyl group of IRL2500
penetrates into the transmembrane core proximal to D2.50, thus
stabilizing the inactive conformation. Using the newly-established
constitutively active mutant, we clearly demonstrate that IRL2500 functions as
an inverse agonist for the ETB receptor. The current findings will
expand the chemical space of ETR antagonists and facilitate the design of
inverse agonists for other class A GPCRs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|